Please use this identifier to cite or link to this item:
|Title:||Analysis of 10B Antitumoral Compounds by Means of Flow-Injection into ESI-MS/MS|
|Authors:||BASILICO F.; SAUERWEIN Wolfgang; POZZI F.; WITTIG Andrea; MOSS RAYMOND; MAURI Pierluigi|
|Citation:||Journal of Mass Spectrometry vol. 40 p. 1546-1549|
|Publisher:||John Wiley & Sons|
|Type:||Articles in periodicals and books|
|Abstract:||Boron neutron capture therapy (BNCT) is a promising binary treatment for cancer. BNCT is based on the ability of the nonradioactive isotope 10B to capture, with a very high probability, thermal neutrons. This nuclear reaction results in two particles (an alpha and a lithium nucleus). The particles have a high biological effectiveness, which is limited in tissue to approximately the diameter of one cell. If the reaction can be limited to a tumor cell, the physical characteristic opens up the possibility to selectively destroy cancer cells, while sparing the surrounding healthy tissue. Quality control of 10B-containing compounds and their distribution at present are very important, and different analytical methods have been developed, such as time-of-flight secondary ion mass spectrometry (TOF-SIMS), electron energy loss spectrometry (EELS), prompt gamma analysis and inductively coupled plasma-optical emission spectrometry (ICPOES). These methods allow the analyses of 10B, but it is not possible to characterize the specific molecular compounds containing 10B. For this reason, we propose a fast and quantitative method that permits the determination of closo-undecahydro-1-mercaptododecaborate (BSH) and 10boron-phenylalanine (BPA) and their eventual metabolites. In particular, 10B-containing compounds are detected by means of flow injection electrospray tandem mass spectrometry (FI/ESI-MS/MS). This approach allows the identification of Boron compounds, BSH and BPA, using tandem mass spectrometry, and quantitative analysis is also possible (c.v. ±4.7%; n = 5; linear range 10–10 000 ng/ml). Furthermore, 10B-containing compounds were detected in actual biological sample (urine and plasma, diluted 10 000- and 1000-fold, respectively) injecting a small volume (1 µl) of diluted samples.|
|JRC Directorate:||Energy, Transport and Climate|
Files in This Item:
There are no files associated with this item.
Items in repository are protected by copyright, with all rights reserved, unless otherwise indicated.